{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:50:08Z","timestamp":1794981008379,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012399","name":"U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","award":["75A50119C00034, 75A50119C00044, and 75A50122C00069"],"award-info":[{"award-number":["75A50119C00034, 75A50119C00044, and 75A50122C00069"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lack of reliable diagnostics for the presence, type and severity of infection in patients presenting to emergency departments with non-specific symptoms poses considerable challenges. We developed TriVerity, which uses isothermal amplification of 29 mRNAs and machine learning algorithms on the Myrna instrument to determine likelihoods of bacterial infection, viral infection and need for critical care interventions within 7 days. To validate TriVerity, the SEPSIS-SHIELD study enrolled 1,222 patients with clinically adjudicated infection status and need for critical care intervention within 7 days as endpoints. The TriVerity Bacterial and Viral scores had higher accuracy than C-reactive protein, procalcitonin or white blood cell count for the diagnosis of bacterial infection with area under the receiver operating characteristic (AUROC) of 0.83, and viral infection (AUROC = 0.91). The TriVerity Severity score had an AUROC of 0.78 for predicting illness severity and allowed reclassification of risk for critical care interventions compared to clinical assessment (quick Sequential Organ Failure Assessment) alone. Each of the three scores had rule-in specificity &gt;92% and rule-out sensitivity &gt;95%. Comparison of antibiotics administration at presentation with post-follow-up adjudication found that TriVerity could potentially reduce false positives and false negatives for inappropriate antibiotics use by 60\u201370%. Further clinical testing in an interventional setting is needed to prove actionability and clinical benefit of TriVerity.<\/jats:p>","DOI":"10.1038\/s41591-025-03933-y","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T09:04:09Z","timestamp":1759223049000},"page":"4044-4054","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Clinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsis"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4348-5509","authenticated-orcid":false,"given":"Oliver","family":"Liesenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom P.","family":"Aufderheide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey M.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"DeVos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-3911","authenticated-orcid":false,"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"House","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1703-5379","authenticated-orcid":false,"given":"Jasreen Kaur","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon E.","family":"Mace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany M.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Panacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9300-3045","authenticated-orcid":false,"given":"Wesley H.","family":"Self","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard A.","family":"Smithline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Steingrub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Van Heukelom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2828-5135","authenticated-orcid":false,"given":"Donna M.","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7145-9105","authenticated-orcid":false,"given":"David W.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1732-4338","authenticated-orcid":false,"given":"Ljubomir","family":"Buturovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehudit","family":"Hasin-Brumshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandita","family":"Damaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cici","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua R.","family":"Shak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9937-9687","authenticated-orcid":false,"given":"Natalie N.","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4143-4708","authenticated-orcid":false,"given":"Purvesh","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3596-1093","authenticated-orcid":false,"given":"Timothy E.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan I.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"3933_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"3933_CR2","unstructured":"Evans, L. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit. Care Med. 47, 1181\u20131247 (2021)."},{"key":"3933_CR3","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMra2403213","volume":"391","author":"NJ Meyer","year":"2024","unstructured":"Meyer, N. J. & Prescott, H. C. Sepsis and septic shock. N. Engl. J. Med. 391, 2133\u20132146 (2024).","journal-title":"N. Engl. J. Med."},{"key":"3933_CR4","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour, C. W. et al. Time to treatment and mortality during mandated emergency care for sepsis. N. Engl. J. Med. 376, 2235\u20132244 (2017).","journal-title":"N. Engl. J. Med."},{"key":"3933_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.chest.2019.02.008","volume":"155","author":"ID Peltan","year":"2019","unstructured":"Peltan, I. D. et al. ED door-to-antibiotic time and long-term mortality in sepsis. Chest 155, 938\u2013946 (2019).","journal-title":"Chest"},{"key":"3933_CR6","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1513\/AnnalsATS.201809-646PS","volume":"16","author":"HC Prescott","year":"2019","unstructured":"Prescott, H. C. & Iwashyna, T. J. Improving sepsis treatment by embracing diagnostic uncertainty. Ann. Am. Thorac. Soc. 16, 426\u2013429 (2019).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"3933_CR7","doi-asserted-by":"crossref","unstructured":"Ducharme, J. et al. A multi-mRNA host-response molecular blood test for the diagnosis and prognosis of acute infections and sepsis: proceedings from a clinical advisory panel. J. Pers. Med. 10, 266 (2020).","DOI":"10.3390\/jpm10040266"},{"key":"3933_CR8","doi-asserted-by":"crossref","unstructured":"Gunsolus, I. L., Sweeney, T. E., Liesenfeld, O. & Ledeboer, N. A. Diagnosing and managing sepsis by probing the host response to infection: advances, opportunities, and challenges. J. Clin. Microbiol. 57, e00425-19 (2019).","DOI":"10.1128\/JCM.00425-19"},{"key":"3933_CR9","doi-asserted-by":"crossref","unstructured":"Jain, S., Self, W. H., Wunderink, R. G. & CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization. N. Engl. J. Med. 373, 2382 (2015).","DOI":"10.1056\/NEJMc1511751"},{"key":"3933_CR10","doi-asserted-by":"publisher","first-page":"e2249353","DOI":"10.1001\/jamanetworkopen.2022.49353","volume":"6","author":"T Ohnuma","year":"2023","unstructured":"Ohnuma, T. et al. Association of appropriate empirical antimicrobial therapy with in-hospital mortality in patients with bloodstream infections in the US. JAMA Netw. Open 6, e2249353 (2023).","journal-title":"JAMA Netw. Open"},{"key":"3933_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/01.CCM.0000253407.89594.15","volume":"35","author":"E Simchen","year":"2007","unstructured":"Simchen, E. et al. Survival of critically ill patients hospitalized in and out of intensive care. Crit. Care Med. 35, 449\u2013457 (2007).","journal-title":"Crit. Care Med."},{"key":"3933_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41746-023-00986-6","volume":"7","author":"A Boussina","year":"2024","unstructured":"Boussina, A. et al. Impact of a deep learning sepsis prediction model on quality of care and survival. NPJ Digit. Med. 7, 14 (2024).","journal-title":"NPJ Digit. Med."},{"key":"3933_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41746-023-00803-0","volume":"6","author":"S Sundrani","year":"2023","unstructured":"Sundrani, S. et al. Predicting patient decompensation from continuous physiologic monitoring in the emergency department. NPJ Digit. Med. 6, 60 (2023).","journal-title":"NPJ Digit. Med."},{"key":"3933_CR14","doi-asserted-by":"crossref","unstructured":"He, Y. D. et al. The optimization and biological significance of a 29-host-immune-mRNA panel for the diagnosis of acute infections and sepsis. J. Pers. Med. 11, 735 (2021).","DOI":"10.3390\/jpm11080735"},{"key":"3933_CR15","doi-asserted-by":"publisher","first-page":"346ra391","DOI":"10.1126\/scitranslmed.aaf7165","volume":"8","author":"TE Sweeney","year":"2016","unstructured":"Sweeney, T. E., Wong, H. R. & Khatri, P. Robust classification of bacterial and viral infections via integrated host gene expression diagnostics. Sci. Transl. Med. 8, 346ra391 (2016).","journal-title":"Sci. Transl. Med."},{"key":"3933_CR16","doi-asserted-by":"publisher","first-page":"287ra271","DOI":"10.1126\/scitranslmed.aaa5993","volume":"7","author":"TE Sweeney","year":"2015","unstructured":"Sweeney, T. E., Shidham, A., Wong, H. R. & Khatri, P. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci. Transl. Med. 7, 287ra271 (2015).","journal-title":"Sci. Transl. Med."},{"key":"3933_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03078-2","volume":"9","author":"TE Sweeney","year":"2018","unstructured":"Sweeney, T. E. et al. A community approach to mortality prediction in sepsis via gene expression analysis. Nat. Commun. 9, 694 (2018).","journal-title":"Nat. Commun."},{"key":"3933_CR18","doi-asserted-by":"crossref","unstructured":"Galtung, N. et al. Prospective validation of a transcriptomic severity classifier among patients with suspected acute infection and sepsis in the emergency department. Eur. J. Emerg. Med. 29, 357\u2013365 (2022).","DOI":"10.1097\/MEJ.0000000000000931"},{"key":"3933_CR19","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1097\/CCM.0000000000005119","volume":"49","author":"W Bauer","year":"2021","unstructured":"Bauer, W. et al. A novel 29-messenger RNA host-response assay from whole blood accurately identifies bacterial and viral infections in patients presenting to the emergency department with suspected infections: a prospective observational study. Crit. Care Med. 49, 1664\u20131673 (2021).","journal-title":"Crit. Care Med."},{"key":"3933_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-021-00394-8","volume":"9","author":"A Safarika","year":"2021","unstructured":"Safarika, A. et al. A 29-mRNA host response test from blood accurately distinguishes bacterial and viral infections among emergency department patients. Intensive Care Med. Exp. 9, 31 (2021).","journal-title":"Intensive Care Med. Exp."},{"key":"3933_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/SHK.0000000000001970","volume":"58","author":"A Kostaki","year":"2022","unstructured":"Kostaki, A. et al. A 29-mRNA host response whole-blood signature improves prediction of 28-day mortality and 7-day intensive care unit care in adults presenting to the emergency department with suspected acute infection and\/or sepsis. Shock 58, 224\u2013230 (2022).","journal-title":"Shock"},{"key":"3933_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116382","volume":"110","author":"NN Whitfield","year":"2024","unstructured":"Whitfield, N. N. et al. A standardized protocol using clinical adjudication to define true infection status in patients presenting to the emergency department with suspected infections and\/or sepsis. Diagn. Microbiol. Infect. Dis. 110, 116382 (2024).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"3933_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/0272989X221121279","volume":"43","author":"SP Taylor","year":"2023","unstructured":"Taylor, S. P. et al. A quantitative study of decision thresholds for initiation of antibiotics in suspected sepsis. Med. Decis. Making 43, 175\u2013182 (2023).","journal-title":"Med. Decis. Making"},{"key":"3933_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1056\/NEJMclde1809210","volume":"380","author":"MY Mi","year":"2019","unstructured":"Mi, M. Y., Klompas, M. & Evans, L. Early administration of antibiotics for suspected sepsis. N. Engl. J. Med. 380, 593\u2013596 (2019).","journal-title":"N. Engl. J. Med."},{"key":"3933_CR25","doi-asserted-by":"crossref","unstructured":"Carroll, K. C. Assessment of MeMed BV assays for differentiating between bacterial and viral respiratory infections. Expert Rev. Mol. Diagn. 24, 873\u2013884 (2024).","DOI":"10.1080\/14737159.2024.2408743"},{"key":"3933_CR26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.emc.2018.06.012","volume":"36","author":"M Pulia","year":"2018","unstructured":"Pulia, M., Redwood, R. & May, L. Antimicrobial stewardship in the emergency department. Emerg. Med. Clin. North Am. 36, 853\u2013872 (2018).","journal-title":"Emerg. Med. Clin. North Am."},{"key":"3933_CR27","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","volume":"177","author":"PD Tamma","year":"2017","unstructured":"Tamma, P. D., Avdic, E., Li, D. X., Dzintars, K. & Cosgrove, S. E. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern. Med. 177, 1308\u20131315 (2017).","journal-title":"JAMA Intern. Med."},{"key":"3933_CR28","doi-asserted-by":"publisher","first-page":"e0161721","DOI":"10.1371\/journal.pone.0161721","volume":"11","author":"S Dittrich","year":"2016","unstructured":"Dittrich, S. et al. Target product profile for a diagnostic assay to differentiate between bacterial and non-bacterial infections and reduce antimicrobial overuse in resource-limited settings: an expert consensus. PLoS ONE 11, e0161721 (2016).","journal-title":"PLoS ONE"},{"key":"3933_CR29","doi-asserted-by":"publisher","first-page":"e2234588","DOI":"10.1001\/jamanetworkopen.2022.34588","volume":"5","author":"NI Shapiro","year":"2022","unstructured":"Shapiro, N. I. et al. Diagnostic accuracy of a bacterial and viral biomarker point-of-care test in the outpatient setting. JAMA Netw. Open 5, e2234588 (2022).","journal-title":"JAMA Netw. Open"},{"key":"3933_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ajem.2022.11.022","volume":"65","author":"D Novak","year":"2023","unstructured":"Novak, D. et al. MeMed BV testing in emergency department patients presenting with febrile illness concerning for respiratory tract infection. Am. J. Emerg. Med. 65, 195\u2013199 (2023).","journal-title":"Am. J. Emerg. Med."},{"key":"3933_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02305-22","volume":"10","author":"N Ram-Mohan","year":"2022","unstructured":"Ram-Mohan, N. et al. Using a 29-mRNA host response classifier to detect bacterial coinfections and predict outcomes in COVID-19 patients presenting to the emergency department. Microbiol. Spectr. 10, e0230522 (2022).","journal-title":"Microbiol. Spectr."},{"key":"3933_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac437","volume":"9","author":"W Bauer","year":"2022","unstructured":"Bauer, W. et al. Detection of viral infection and bacterial coinfection and superinfection in coronavirus disease 2019 patients presenting to the emergency department using the 29-mRNA host response classifier IMX-BVN-3: a multicenter study. Open Forum Infect. Dis. 9, ofac437 (2022).","journal-title":"Open Forum Infect. Dis."},{"key":"3933_CR33","doi-asserted-by":"publisher","first-page":"e241339","DOI":"10.1001\/jamahealthforum.2024.1339","volume":"5","author":"DE Newman-Toker","year":"2024","unstructured":"Newman-Toker, D. E. & Sharfstein, J. M. The role for policy in AI-assisted medical diagnosis. JAMA Health Forum 5, e241339 (2024).","journal-title":"JAMA Health Forum"},{"key":"3933_CR34","doi-asserted-by":"crossref","unstructured":"Rhee, C. et al. Infectious Diseases Society of America position paper: recommended revisions to the national Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) sepsis quality measure. Clin. Infect. Dis. 72, 541\u2013552 (2020).","DOI":"10.1093\/cid\/ciaa059"},{"key":"3933_CR35","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/cid\/ciaa456","volume":"72","author":"AL Pakyz","year":"2021","unstructured":"Pakyz, A. L. et al. Impact of the Centers for Medicare and Medicaid Services sepsis core measure on antibiotic use. Clin. Infect. Dis. 72, 556\u2013565 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"3933_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.2016.20329","volume":"317","author":"Y Freund","year":"2017","unstructured":"Freund, Y. et al. Prognostic accuracy of Sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA 317, 301\u2013308 (2017).","journal-title":"JAMA"},{"key":"3933_CR37","unstructured":"Balk, R. et al. Rapid and robust identification of sepsis using SeptiCyte RAPID in a heterogeneous patient population. J Clin. Med. 13, 6044 (2024)."},{"key":"3933_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08331-5","volume":"22","author":"EL Linnander","year":"2022","unstructured":"Linnander, E. L. et al. Mitigating structural racism to reduce inequities in sepsis outcomes: a mixed methods, longitudinal intervention study. BMC Health Serv. Res. 22, 975 (2022).","journal-title":"BMC Health Serv. Res."},{"key":"3933_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1473-3099(16)30519-9","volume":"17","author":"CB van Houten","year":"2017","unstructured":"van Houten, C. B. et al. A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study. Lancet Infect. Dis. 17, 431\u2013440 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"3933_CR40","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.cmi.2023.05.033","volume":"29","author":"S Halabi","year":"2023","unstructured":"Halabi, S. et al. Host test based on tumor necrosis factor-related apoptosis-inducing ligand, interferon gamma-induced protein-10 and C-reactive protein for differentiating bacterial and viral respiratory tract infections in adults: diagnostic accuracy study. Clin. Microbiol. Infect. 29, 1159\u20131165 (2023).","journal-title":"Clin. Microbiol. Infect."},{"key":"3933_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.13167","volume":"5","author":"RG Bachur","year":"2024","unstructured":"Bachur, R. G. et al. A rapid host\u2013protein test for differentiating bacterial from viral infection: Apollo diagnostic accuracy study. J. Am. Coll. Emerg. Physicians Open 5, e13167 (2024).","journal-title":"J. Am. Coll. Emerg. Physicians Open"},{"key":"3933_CR42","doi-asserted-by":"crossref","unstructured":"Martin, L. S. et al. Diagnostic accuracy of LIAISON MeMed VB\u00ae for bacteremia in the emergency department. Enferm. Infecc. Microbiol. Clin. (Engl. Ed.) 43, 302\u2013303 (2025).","DOI":"10.1016\/j.eimce.2025.01.007"},{"key":"3933_CR43","first-page":"154","volume":"259","author":"L Buturovic","year":"2025","unstructured":"Buturovic, L. et al. Development of machine learning classifiers for blood-based diagnosis and prognosis of suspected acute infections and sepsis. Proc. Mach. Learn. Res. 259, 154\u2013170 (2025).","journal-title":"Proc. Mach. Learn. Res."},{"key":"3933_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14975-w","volume":"11","author":"MB Mayhew","year":"2020","unstructured":"Mayhew, M. B. et al. A generalizable 29-mRNA neural-network classifier for acute bacterial and viral infections. Nat. Commun. 11, 1177 (2020).","journal-title":"Nat. Commun."},{"key":"3933_CR45","first-page":"e0554","volume":"3","author":"SC Brakenridge","year":"2021","unstructured":"Brakenridge, S. C. et al. A transcriptomic severity metric that predicts clinical outcomes in critically ill surgical sepsis patients. Crit. Care Explor. 3, e0554 (2021).","journal-title":"Crit. Care Explor."},{"key":"3933_CR46","doi-asserted-by":"publisher","first-page":"e2221520","DOI":"10.1001\/jamanetworkopen.2022.21520","volume":"5","author":"SC Brakenridge","year":"2022","unstructured":"Brakenridge, S. C. et al. Evaluation of a multivalent transcriptomic metric for diagnosing surgical sepsis and estimating mortality among critically ill patients. JAMA Netw. Open 5, e2221520 (2022).","journal-title":"JAMA Netw. Open"},{"key":"3933_CR47","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/clinchem\/hvab275","volume":"68","author":"MC Remmel","year":"2022","unstructured":"Remmel, M. C., Coyle, S. M., Eshoo, M. W., Sweeney, T. E. & Rawling, D. C. Diagnostic host gene expression analysis by quantitative reverse transcription loop-mediated isothermal amplification to discriminate between bacterial and viral infections. Clin. Chem. 68, 550\u2013560 (2022).","journal-title":"Clin. Chem."},{"key":"3933_CR48","doi-asserted-by":"publisher","unstructured":"Figueiredo-Pereira, C. et al. Analytical evaluation of TriVerity, a rapid diagnostic and prognostic host gene expression test performed on the Myrna instrument using RT-LAMP. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/jcm.00352-25 (2025).","DOI":"10.1128\/jcm.00352-25"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03933-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03933-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03933-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:00:05Z","timestamp":1765814405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03933-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3933"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03933-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5194992\/v1","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutions of all principal investigators received research support for the conduct of the current SEPSIS-SHIELD study. O.L. is an advisor to and owns stock options in Inflammatix, Inc. T.A. holds unrestricted research grants for clinical trial implementation from the National Institutes of Health, the National Institute of Neurological Disorders and Stroke, the National Heart, Lung, and Blood Institute, ZOLL Medical, Inflammatix, Cytovale, Abbott and AstraZeneca; received equipment support for unrestricted clinical trial implementation from ZOLL Medical and Moberg ICU Solutions; and received honoraria for consultanting from Medtronic. C.C. received honoraria for research consultation from Inflammatix and Vail Scientific. E.J.G.-B. has received honoraria from Abbott Products Operations, bioM\u00e9rieux, Sobi and Thermo Fisher Brahms; independent educational grants from Abbott Products Operations, bioM\u00e9rieux, Gentian, InCyte, Merck Sharp & Dohme, Novartis, UCB, PHC Europe BV and Swedish Orphan Biovitrum AB (publ) (Sobi); and funding from the Horizon 2020 European grants ImmunoSep and RISCinCOVID and the Horizon Health grant EPIC-CROWN-2, Homi-LUNG and POINT (granted to the Hellenic Institute for the Study of Sepsis or to the National and Kapodistrian University of Athens). L.M. received honoraria for speaking engagements from Inflammatix. T.O. received funding from Beckman Coulter and participated in the Centers for Medicare and Medicaid Services Measure Instrument Development and Support (MIDS) patient safety project: Sepsis Outcome Measure Technical Expert Panel. R.E.R. received remuneration for participation on advisory boards for Inflammatix, Cytovale, MeMed, Cepheid, Roche and Immunexpress. He served as site principal investigator for Johns Hopkins University with grant support for study activities for other Inflammatix-sponsored research and conducted sponsored research from Cytovale, MeMed, Beckman Coulter, Abbott and Immunexpress. R.E.R. also participated in national educational conferences with paid remuneration from Inflammatix and Cepheid. W.S. reports receiving payment from Inflammatix in 2019 for serving on a scientific advisory board. A.W. received consultation fees from Inflammatix. L.B, Y.H.B., N.D. and N.N.W. are employees and stock option holders of Inflammatix. C.L. and J.R.S. hold stock options in Inflammatix. P.K. is a co-founder of, a consultant to and a scientific advisor to Inflammatix. T.E.S. is a co-founder, employee and stock option holder of Inflammtix. N.S. received funding from Bluejay Diagnostics and Inflammatix and reports personal financial interest in Prenosis. S.A., E.D., M.F., S.H., R.H., J. K.G., E.L., S.M., E.M., E.P., H.S., J.S., P.V., M.W., D.M.W. and D.W.W. declare no conflicts of interest or relevant competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}